Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
64 participants
OBSERVATIONAL
2021-12-01
2022-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Auditory Sensory Attenuation in Obesity
NCT06298539
Functional Magnetic Resonance Imaging Study of the Central Auditory System After Single Sided Deafness
NCT02534298
Body Mass Index and Audiology Function
NCT03172663
Risk Factors for Hearing Loss as a Result of Exposure to Noise During Military Training in the IDF
NCT03314116
Hearing Loss and Communication Needs in a Group Care Setting for Older Adults
NCT04659967
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators have collected preliminary results in a sample of blind women (N = 18) in Israel. The investigators plan to a) expand the data collection in Israel to reach a sample of 30 blind women and to b) carry out a full replication of the study in an independent sample of blind and sighted women in the US. Data have not been collected yet for the US replication study. Based on the effect size of the the implicit bias effect (represented by the IAT D score) obtained in preliminary results in the Israeli sample (Cohen's D = 0.74), a power analysis using G\*power was carried out and showed that a sample of 22 participants is sufficient to detect the IAT implicit bias effect with a power \> 95% and an a-priori alpha set at 0.05.
Based on preliminary results in the Israeli sample, it is hypothesized that:
1. Blind women will demonstrate an implicit bias indicating preference for thin bodies and a dislike of overweight bodies. This effect will be reflected by slower response times when words describing thin bodies will be coupled with negative compared to positive words and when words describing overweight bodies will be coupled with positive compared to negative words. This implicit bias effect will be computed using the IAT's D algorithm.
2. The implicit anti-fat bias effect (IAT D-score) will be comparable between sighted and blind women.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blind women
The blind women group will include women who are congenitally blind or that were blinded early in life (up to the age of 7).
No interventions assigned to this group
Sighted women
Women with normal or corrected-to-normal eye sight.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Congenitally blind or blinded no later than the age of 7.
* Inability to see themselves in the mirror.
* Inability to recognize other people's faces or bodies.
* Inability to use visual-based media.
* Fluent English speakers.
* Aged 18-45 years old.
* Corrected or corrected-to-normal vision.
* Fluent English speakers.
Exclusion Criteria
Sighted women
• Any condition that prevents the ability to use a computer.
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Haifa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Noam Weinbach, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Haifa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Haifa
Haifa, Central District, Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
493-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.